SCHEDULED DOWNTIME: We will be performing a database migration that will result in the site being unavailable for approximately 1 hour starting at UTC: Monday, 20 May 2024 11:00 PM (check your local time here

ROS1 mutation

Changed by Daniel J Bell, 5 Aug 2019

Updates to Article Attributes

Title was changed:
ROS 1ROS1 mutation
Body was changed:

The ROS 1ROS1 mutation is a mutation occurring in the ROS 1ROS1 oncogene inon chromosome 6 resulting in a defective receptor tyrosine kinase which has structural similarity to the anaplastic lymphoma kinase (ALK) protein.

It is thought to be present in several cancers of the subtype non-small cell lung cancers (NSCLC) (1-2%).

Clinical importance

Useful for assessing appropriateness of treatment agents such as crizotinib.

History and etymology

It is thought to have been first identified by Rikova et al 3.

See also

  • -<p>The <strong>ROS 1 mutation</strong> is a mutation occurring in the <em>ROS 1</em> oncogene in chromosome 6 resulting in a defective receptor tyrosine kinase which has structural similarity to the anaplastic lymphoma kinase (ALK) protein.</p><p>It is thought to be present in several cancers of the subtype <a title="Non small cell lung cancer" href="/articles/non-small-cell-lung-cancer-2">non-small cell lung cancers (NSCLC)</a> (1-2%).</p><h4>Clinical importance</h4><p>Useful for assessing appropriateness of treatment agents such as crizotinib.</p><h4>History and etymology</h4><p>It is thought to have been first identified by <strong>Rikova</strong> et al <sup>3</sup>.</p><h4>See also</h4><ul>
  • +<p>The <strong>ROS1 mutation</strong> is a mutation occurring in the <em>ROS1</em> oncogene on chromosome 6 resulting in a defective receptor tyrosine kinase which has structural similarity to the anaplastic lymphoma kinase (ALK) protein.</p><p>It is thought to be present in several cancers of the subtype <a href="/articles/non-small-cell-lung-cancer-2">non-small cell lung cancers (NSCLC)</a> (1-2%).</p><h4>Clinical importance</h4><p>Useful for assessing appropriateness of treatment agents such as crizotinib.</p><h4>History and etymology</h4><p>It is thought to have been first identified by <strong>Rikova</strong> et al <sup>3</sup>.</p><h4>See also</h4><ul>

Updates to Link Attributes

Title was removed:
ROS 1 mutation
Type was removed.
Visible was set to .

Updates to Primarylink Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.